Ms. Yeates, excuse me. I have to focus. I'm sorry if I'm cutting your off; I don't mean to be rude. What about the piece that I read out that says, “develop, assess and cost options for catastrophic pharmaceutical coverage”? That specifically was never done. Why not?
On November 20th, 2012. See this statement in context.